Logo image of SGFY

SIGNIFY HEALTH INC -CLASS A (SGFY) Stock Fundamental Analysis

NYSE:SGFY - New York Stock Exchange, Inc. - US82671G1004 - Common Stock - Currency: USD

30.49  +0.02 (+0.07%)

After market: 30.49 0 (0%)

Fundamental Rating

4

SGFY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. SGFY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SGFY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SGFY had negative earnings in the past year.
SGFY had a positive operating cash flow in the past year.
In the past 5 years SGFY reported 4 times negative net income.
In the past 5 years SGFY always reported a positive cash flow from operatings.
SGFY Yearly Net Income VS EBIT VS OCF VS FCFSGFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -200M -400M

1.2 Ratios

SGFY has negative profitability rations, so we won't be analyzing them here.
With a decent Return On Invested Capital value of 6.14%, SGFY is doing good in the industry, outperforming 67.26% of the companies in the same industry.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SGFY Yearly ROA, ROE, ROICSGFY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 -20 -40 -60 -80

1.3 Margins

SGFY's Operating Margin of 13.53% is amongst the best of the industry. SGFY outperforms 89.38% of its industry peers.
In the last couple of years the Operating Margin of SGFY has grown nicely.
SGFY has a Gross Margin of 45.33%. This is in the better half of the industry: SGFY outperforms 72.57% of its industry peers.
SGFY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.53%
PM (TTM) N/A
GM 45.33%
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
SGFY Yearly Profit, Operating, Gross MarginsSGFY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

SGFY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SGFY has more shares outstanding than it did 1 year ago.
SGFY has a worse debt/assets ratio than last year.
SGFY Yearly Shares OutstandingSGFY Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 50M 100M 150M 200M
SGFY Yearly Total Debt VS Total AssetsSGFY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 3.36 indicates that SGFY is not in any danger for bankruptcy at the moment.
The Altman-Z score of SGFY (3.36) is better than 76.99% of its industry peers.
The Debt to FCF ratio of SGFY is 93.50, which is on the high side as it means it would take SGFY, 93.50 years of fcf income to pay off all of its debts.
SGFY has a Debt to FCF ratio of 93.50. This is comparable to the rest of the industry: SGFY outperforms 52.21% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that SGFY is somewhat dependend on debt financing.
SGFY has a Debt to Equity ratio of 0.53. This is in the better half of the industry: SGFY outperforms 60.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Altman-Z 3.36
ROIC/WACC0.66
WACC9.37%
SGFY Yearly LT Debt VS Equity VS FCFSGFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
The Current ratio of SGFY (1.62) is better than 67.26% of its industry peers.
A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.62, SGFY is in the better half of the industry, outperforming 72.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
SGFY Yearly Current Assets VS Current LiabilitesSGFY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

SGFY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -390.91%.
The Revenue has grown by 23.33% in the past year. This is a very strong growth!
Measured over the past years, SGFY shows a quite strong growth in Revenue. The Revenue has been growing by 17.09% on average per year.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%

3.2 Future

SGFY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 93.52% yearly.
Based on estimates for the next years, SGFY will show a quite strong growth in Revenue. The Revenue will grow by 18.33% on average per year.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SGFY Yearly Revenue VS EstimatesSGFY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
SGFY Yearly EPS VS EstimatesSGFY Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 94.60, the valuation of SGFY can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as SGFY.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, SGFY is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 94.6
SGFY Price Earnings VS Forward Price EarningsSGFY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

SGFY's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as SGFY.
Industry RankSector Rank
P/FCF 1516.44
EV/EBITDA 32.74
SGFY Per share dataSGFY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

SGFY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGFY's earnings are expected to grow with 93.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.26%, SGFY has a reasonable but not impressive dividend return.
SGFY's Dividend Yield is rather good when compared to the industry average which is at 3.01. SGFY pays more dividend than 85.84% of the companies in the same industry.
With a Dividend Yield of 1.26, SGFY pays less dividend than the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 1.26%

5.2 History

SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
SGFY Yearly Income VS Free CF VS DividendSGFY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 0 -200M -400M

SIGNIFY HEALTH INC -CLASS A

NYSE:SGFY (3/28/2023, 8:04:01 PM)

After market: 30.49 0 (0%)

30.49

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-07 2023-03-07/dmh
Earnings (Next)05-02 2023-05-02
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.46%
Ins Owner Change0%
Market Cap5.46B
Analysts70
Price Target30.01 (-1.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.26%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-788.65%
Min EPS beat(2)-1114.2%
Max EPS beat(2)-463.11%
EPS beat(4)1
Avg EPS beat(4)-261.16%
Min EPS beat(4)-1114.2%
Max EPS beat(4)761.79%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.89%
Min Revenue beat(2)-42.43%
Max Revenue beat(2)-11.35%
Revenue beat(4)0
Avg Revenue beat(4)-14.07%
Min Revenue beat(4)-42.43%
Max Revenue beat(4)-0.2%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-51.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 94.6
P/S 6.78
P/FCF 1516.44
P/OCF 171.13
P/B 8.7
P/tB N/A
EV/EBITDA 32.74
EPS(TTM)-0.32
EYN/A
EPS(NY)0.32
Fwd EY1.06%
FCF(TTM)0.02
FCFY0.07%
OCF(TTM)0.18
OCFY0.58%
SpS4.5
BVpS3.5
TBVpS-0.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 6.14%
ROICexc 9.77%
ROICexgc N/A
OM 13.53%
PM (TTM) N/A
GM 45.33%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)5.48%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y104.84%
ROICexc growth 5YN/A
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 93.5
Debt/EBITDA 2.07
Cap/Depr 52.6%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 3.36
F-Score3
WACC9.37%
ROIC/WACC0.66
Cap/Depr(3y)53.08%
Cap/Depr(5y)45.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Sales Q2Q%232.24%
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
EBIT growth 1Y26.74%
EBIT growth 3Y75.98%
EBIT growth 5YN/A
EBIT Next Year153.12%
EBIT Next 3Y41%
EBIT Next 5Y25.5%
FCF growth 1Y-96.67%
FCF growth 3Y-39.43%
FCF growth 5YN/A
OCF growth 1Y-75.44%
OCF growth 3Y-8.54%
OCF growth 5YN/A